1 |
Erbguth FJ. Historical Notes on Botulism, Clostridium botulinum, Botulinum Toxin, and the Idea of the Therapeutic Use of the Toxin. Mov Disord 2004;19:S2-6.
DOI
|
2 |
Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43:249-59.
DOI
|
3 |
Wheeler A, Smith HS. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology 2013;306:124-46.
DOI
|
4 |
Brin MF, James C, Maltman J. Botulinum toxin type A products are not interchangeable: a review of the evidence. Biologics 2014;8:227-4.
DOI
|
5 |
Song YC. The mechanism of action of Botulinum toxin and various therapeutic uses. Korea pharmaceutical information center;2016.
|
6 |
Andy P. Botulinum Toxin as a Clinical Product: Manufacture and Pharmacology In Clinical Applications of Botulinum Neurotoxin: K. A. Foster, Current Topics in Neurotoxicity 5. Springer Science+Business Media New York;2014.
|
7 |
Kim JE, Song EJ, Choi GS, Lew BL, Sim WY, Kang H. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines. Plast Reconstr Surg 2015;135(3):732-41.
DOI
|
8 |
Cha W, Jang JY, Wang SG, Kang JH, Jo MG. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study. J Voice 2017;31(3):378.e19-378.e24.
DOI
|
9 |
Barrow EM, Rosen CA, Hapner ER, Smith S, Hatcher JL, Simpson B, et al. Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection. Laryngoscope 2015;125(5):1149-54.
DOI
|
10 |
Liu A, Carruthers A, Cohen JL, Coleman WP 3rd, Dover JS, Hanke CW, et al. Recommendations and current practices for the reconstitution and storage of botulinum toxin type A. J Am Acad Dermatol 2012;67(3):373-8.
DOI
|